To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions

NCT00913887 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Diclofenac Sodium 75 mg Tablets Under Fasting Conditions (Geneva Pharmaceutical)
DRUG: Diclofenac Sodium 75 mg Tablets Under Fed Conditions (Geneva Pharmaceutical)
DRUG: Voltaren 75 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals)

Sponsor

Sandoz